| For: | Fargion S, Porzio M, Fracanzani AL. Nonalcoholic fatty liver disease and vascular disease: State-of-the-art. World J Gastroenterol 2014; 20(37): 13306-13324 [PMID: 25309067 DOI: 10.3748/wjg.v20.i37.13306] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i37/13306.htm |
| Number | Citing Articles |
| 1 |
Yurij Stepanov, Natalia Zavhorodnia, Olha Lukianenko, Irina Konenko, Victoria Yahmur, Inna Klenina, Oksana Tatarchuk, Oksana Petishko. Non-invasive arterial stiffness assessment in children with non-alcoholic fatty liver disease. JOURNAL OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE 2019; doi: 10.37621/JNAMSU-2019-4-431-438
|
| 2 |
Vasilios G Athyros. Statins for the Treatment of Non Alcoholic Fatty Liver Disease in Patients with Metabolic Syndrome. Journal of Diabetes, Metabolic Disorders & Control 2016; 3(1) doi: 10.15406/jdmdc.2016.03.00057
|
| 3 |
Suleiman Al Ashi, Ali A. Rizvi, Manfredi Rizzo. Altered kidney function in fatty liver disease: confronting the “MAFLD-renal syndrome”. Frontiers in Clinical Diabetes and Healthcare 2025; 5 doi: 10.3389/fcdhc.2024.1539117
|
| 4 |
Marcio H. Miname, Raul D. Santos. Fatty liver, inflamed blood and calcified coronary arteries: Lessons and uncertainties from the multiethnic study of atherosclerosis -commentary on the study of Al Rifai et al.. Atherosclerosis 2015; 239(2) doi: 10.1016/j.atherosclerosis.2015.02.041
|
| 5 |
Rosa Lombardi, Silvia Fargion, Anna Ludovica Fracanzani. Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review. Digestive and Liver Disease 2019; 51(9) doi: 10.1016/j.dld.2019.05.015
|
| 6 |
Min-Kyung Lee, Hye-Jeong Park, Won Seon Jeon, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee. Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study. Cardiovascular Diabetology 2015; 14(1) doi: 10.1186/s12933-015-0253-9
|
| 7 |
Yedidya Saiman, Andres Duarte-Rojo, Mary E. Rinella. Fatty Liver Disease: Diagnosis and Stratification. Annual Review of Medicine 2022; 73(1) doi: 10.1146/annurev-med-042220-020407
|
| 8 |
Christoph Mahlke, Diego Hernando, Christina Jahn, Antonio Cigliano, Till Ittermann, Anne Mössler, Marie-Luise Kromrey, Grazyna Domaska, Scott B. Reeder, Jens-Peter Kühn. Quantification of liver proton-density fat fraction in 7.1T preclinical MR systems: Impact of the fitting technique. Journal of Magnetic Resonance Imaging 2016; 44(6) doi: 10.1002/jmri.25319
|
| 9 |
Yanchun Li, Zhongyang Lu, Ji Hyun Ru, Maria F. Lopes-Virella, Timothy J. Lyons, Yan Huang. Saturated fatty acid combined with lipopolysaccharide stimulates a strong inflammatory response in hepatocytes in vivo and in vitro. American Journal of Physiology-Endocrinology and Metabolism 2018; 315(5) doi: 10.1152/ajpendo.00015.2018
|
| 10 |
Haneen Azzam, Stephen Malnick. Non-alcoholic fatty liver disease - the heart of the matter. World Journal of Hepatology 2015; 7(10): 1369-1376 doi: 10.4254/wjh.v7.i10.1369
|
| 11 |
Jarkko S. Heiskanen, Saku Ruohonen, Suvi P. Rovio, Ville Kytö, Mika Kähönen, Terho Lehtimäki, Jorma S. A. Viikari, Markus Juonala, Tomi Laitinen, Päivi Tossavainen, Eero Jokinen, Nina Hutri‐Kähönen, Olli T. Raitakari. Determinants of left ventricular diastolic function—The Cardiovascular Risk in Young Finns Study. Echocardiography 2019; 36(5) doi: 10.1111/echo.14321
|
| 12 |
Mauricio Montemezzo, Ahmed AlTurki, Fabio Stahlschmidt, Marcia Olandoski, Jean Rodrigo Tafarel, Dalton Bertolin Precoma. Nonalcoholic Fatty Liver Disease and Coronary Artery Disease: Big Brothers in Patients with Acute Coronary Syndrome. The Scientific World Journal 2020; 2020 doi: 10.1155/2020/8489238
|
| 13 |
Ivana Mikolasevic, Sandra Milic, Tamara Turk Wensveen, Ivana Grgic, Ivan Jakopcic, Davor Stimac, Felix Wensveen, Lidija Orlic. Nonalcoholic fatty liver disease - A multisystem disease?. World Journal of Gastroenterology 2016; 22(43): 9488-9505 doi: 10.3748/wjg.v22.i43.9488
|
| 14 |
Zhihong Ma, Li Chu, Hongying Liu, Jieru Li, Yuanyuan Zhang, Wentai Liu, Jun Dai, Jianfeng Yi, Yue Gao. Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: Involvement with the ROCK/NF-κB pathway. International Immunopharmacology 2016; 38 doi: 10.1016/j.intimp.2016.06.023
|
| 15 |
Min-Hee Gwon, Young-Sun Im, A-Reum Seo, Kyoung Yun Kim, Ha-Rin Moon, Jung-Mi Yun. Phenethyl Isothiocyanate Protects against High Fat/Cholesterol Diet-Induced Obesity and Atherosclerosis in C57BL/6 Mice. Nutrients 2020; 12(12) doi: 10.3390/nu12123657
|
| 16 |
Rita Moretti, Paola Caruso, Silvia Gazzin. Non-alcoholic fatty liver disease and neurological defects. Annals of Hepatology 2019; 18(4) doi: 10.1016/j.aohep.2019.04.007
|
| 17 |
Zheng Lu, Lu Liu, Shunxin Zhao, Jiangtao Zhao, Sujun Li, Mingyang Li. Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-34654-2
|
| 18 |
Magalí Barchuk, Laura Schreier, Gabriela Berg, Verónica Miksztowicz. Metalloproteinases in non-alcoholic fatty liver disease and their behavior in liver fibrosis. Hormone Molecular Biology and Clinical Investigation 2020; 41(1) doi: 10.1515/hmbci-2018-0037
|
| 19 |
Andrea Boccatonda, Damiano D’Ardes, Veronica Moronti, Jessica Santilli, Alessia Cipollone, Gianfranco Lessiani, Nicoletta Di Gregorio, Carla Serra, Fabio Piscaglia, Claudio Ferri, Francesco Cipollone. From MASLD to PAD: Looking for Cardiovascular Disease Starting from Metabolic Status. Medicina 2024; 60(11) doi: 10.3390/medicina60111781
|
| 20 |
Ronald L. Koretz. JPEN Journal Club 16. Trial Registries. Journal of Parenteral and Enteral Nutrition 2015; 39(8) doi: 10.1177/0148607115601985
|
| 21 |
Lei Liu, Yufu Zhou, Shuwen Deng, Ting Yuan, Saiqi Yang, Xiaoling Zhu, Changfa Wang, Yaqin Wang. Arterial stiffness progression in metabolic dysfunction–associated fatty liver disease subtypes: A prospective cohort study. Nutrition, Metabolism and Cardiovascular Diseases 2024; 34(8) doi: 10.1016/j.numecd.2024.03.030
|
| 22 |
Narendra S. Choudhary, Sanjiv Saigal. Preventive Strategies for Nonalcoholic Fatty Liver Disease After Liver Transplantation. Journal of Clinical and Experimental Hepatology 2019; 9(5) doi: 10.1016/j.jceh.2019.05.004
|
| 23 |
Niketa Sharma, Swarupa Chakole, Bhushan Wandile. Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease. Cureus 2023; doi: 10.7759/cureus.46946
|
| 24 |
Jean-Baptiste Moretti, Amélia Drouin, Caroline Truong, Elizabeth Youn, Anik Cloutier, Fernando Alvarez, Massimiliano Paganelli, Kelly Grzywacz, Prevost Jantchou, Josee Dubois, Emile Levy, Ramy El Jalbout. Effects of polyphenol supplementation on hepatic steatosis, intima-media thickness and non-invasive vascular elastography in obese adolescents: a pilot study protocol. BMJ Open 2024; 14(1) doi: 10.1136/bmjopen-2023-074882
|
| 25 |
R. A Eganyan. The role of non-alcoholic fatty liver disease in the development of cardiovascular diseases. CardioSomatics 2018; 9(1) doi: 10.26442/CS45957
|
| 26 |
Alessia Di Costanzo, Laura D'Erasmo, Licia Polimeni, Francesco Baratta, Paola Coletta, Michele Di Martino, Lorenzo Loffredo, Ludovica Perri, Fabrizio Ceci, Anna Montali, Gabriella Girelli, Bruna De Masi, Antonio Angeloni, Carlo Catalano, Marianna Maranghi, Maria Del Ben, Francesco Angelico, Marcello Arca. Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage. Atherosclerosis 2017; 257 doi: 10.1016/j.atherosclerosis.2016.12.018
|
| 27 |
M. Nascimento, R. Piran, R.M. Da Costa, M.A. Giordani, F.S. Carneiro, D.H. Aguiar, M.C. Dias, M.M. Sugizaki, R.A. Luvizotto, A.F. Nascimento, G.F. Bomfim. Hepatic injury induced by thioacetamide causes aortic endothelial dysfunction by a cyclooxygenase-dependent mechanism. Life Sciences 2018; 212 doi: 10.1016/j.lfs.2018.09.051
|
| 28 |
Melissa Maritz, Carla M.T. Fourie, Johannes M. Van Rooyen, Sarah J. Moss, Aletta E. Schutte. Large artery stiffness is associated with gamma-glutamyltransferase in young, healthy adults: The African-PREDICT study. Journal of the American Society of Hypertension 2016; 10(10) doi: 10.1016/j.jash.2016.07.006
|
| 29 |
Yu-Tao Zhan, Hai-Ying Su, Wei An. Glycosyltransferases and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(8): 2483-2493 doi: 10.3748/wjg.v22.i8.2483
|
| 30 |
Steven C. Lin, Brandon Ang, Carolyn Hernandez, Ricki Bettencourt, Rashmi Jain, Joanie Salotti, Lisa Richards, Yuko Kono, Archana Bhatt, Hamed Aryafar, Grace Y. Lin, Mark A. Valasek, Claude B. Sirlin, Sharon Brouha, Rohit Loomba. Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial. Therapeutic Advances in Gastroenterology 2016; 9(2) doi: 10.1177/1756283X15621232
|
| 31 |
Shukang Wang, Chengqi Zhang, Guang Zhang, Zhongshang Yuan, Yanxun Liu, Lijie Ding, Xiubin Sun, Hongying Jia, Fuzhong Xue. Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study. BMJ Open 2016; 6(6) doi: 10.1136/bmjopen-2015-010342
|
| 32 |
Caifeng Xie, Zhen Chen, Chengfu Zhang, Xin Xu, Jiangbo Jin, Weihua Zhan, Tianyu Han, Jianbin Wang. Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress. Life Sciences 2016; 157 doi: 10.1016/j.lfs.2016.06.001
|
| 33 |
Qian Li, Manish Dhyani, Joseph R Grajo, Claude Sirlin, Anthony E Samir. Current status of imaging in nonalcoholic fatty liver disease. World Journal of Hepatology 2018; 10(8): 530-542 doi: 10.4254/wjh.v10.i8.530
|
| 34 |
Przemysław Cheładze, Adrian Martuszewski, Rafał Poręba, Paweł Gać. The Importance of the Assessment of Epicardial Adipose Tissue in Scientific Research. Journal of Clinical Medicine 2022; 11(19) doi: 10.3390/jcm11195621
|
| 35 |
Huanhuan Zhou, Chenghuan Zhang, Jingyu Ni, Xiaoyun Han. Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China. BMC Endocrine Disorders 2019; 19(1) doi: 10.1186/s12902-019-0427-7
|
| 36 |
Ruiyang Zhao, Yuxin Zhang, Xiaoke Wang, Timothy J. Colgan, Jennifer L. Rehm, Scott B. Reeder, Kevin M. Johnson, Diego Hernando. Motion‐robust, high‐SNR liver fat quantification using a 2D sequential acquisition with a variable flip angle approach. Magnetic Resonance in Medicine 2020; 84(4) doi: 10.1002/mrm.28263
|
| 37 |
Mandana Khalili, Wendy C King, David E Kleiner, Mamta K Jain, Raymond T Chung, Mark Sulkowski, Mauricio Lisker-Melman, David K Wong, Marc Ghany, Arun Sanyal, Richard K Sterling. Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection. Clinical Infectious Diseases 2021; 73(9) doi: 10.1093/cid/ciaa1303
|
| 38 |
Weiyu Hou, Fanrui Zhao, Li Fang, Xiyan Wang, Dan Wu, Chunlei Liu, Yue Leng, Yawen Gao, Junxi Fu, Ji Wang, Weihong Min. Walnut-Derived Peptides Promote Autophagy via the Activation of AMPK/mTOR/ULK1 Pathway to Ameliorate Hyperglycemia in Type 2 Diabetic Mice. Journal of Agricultural and Food Chemistry 2023; 71(8) doi: 10.1021/acs.jafc.2c07112
|
| 39 |
Teruki Miyake, Bunzo Matsuura, Shinya Furukawa, Yasuhiko Todo, Shin Yamamoto, Osamu Yoshida, Yusuke Imai, Takao Watanabe, Yasunori Yamamoto, Masashi Hirooka, Yoshio Tokumoto, Teru Kumagi, Masanori Abe, Hirotaka Seike, Shozo Miyauchi, Yoichi Hiasa. Hyperthyroidism Improves the Pathological Condition of Nonalcoholic Steatohepatitis: A Case of Nonalcoholic Steatohepatitis with Graves' Disease. Internal Medicine 2016; 55(15) doi: 10.2169/internalmedicine.55.6640
|
| 40 |
Luuk J.J. Scheres, Astrid van Hylckama Vlieg, Bart E.P.B. Ballieux, Bart C.J.M. Fauser, Frits R. Rosendaal, Saskia Middeldorp, Suzanne C. Cannegieter. Endogenous sex hormones and risk of venous thromboembolism in young women. Journal of Thrombosis and Haemostasis 2019; 17(8) doi: 10.1111/jth.14474
|
| 41 |
Narendra Singh Choudhary, Neeraj Saraf, Mohammad Shai Kuchay, Ravi R Kasliwal. The association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease. Journal of Clinical and Preventive Cardiology 2021; 10(3) doi: 10.4103/jcpc.jcpc_31_21
|
| 42 |
Salvatore Pezzino, Tonia Luca, Mariacarla Castorina, Stefano Puleo, Saverio Latteri, Sergio Castorina. Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines. Life 2024; 14(1) doi: 10.3390/life14010093
|
| 43 |
Sean Sileno, Razvan M. Chirila, Dana M. Harris. Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians. Romanian Journal of Internal Medicine 2020; 58(4) doi: 10.2478/rjim-2020-0018
|
| 44 |
Thomas D Ruder, Wolf Schweitzer, Garyfalia Ampanozi, Dominic Gascho, Patricia M Flach, Michael J Thali, Gary M Hatch. Imaging findings of diabetes on post-mortem CT. Journal of Forensic Radiology and Imaging 2018; 13 doi: 10.1016/j.jofri.2018.05.002
|
| 45 |
Wen-Hua Zhu, Li-Zheng Fang, Chong-Rong Lu, Hong-Lei Dai, Jian-Hua Chen, Qiao-Hua Qiao, Li-Ying Chen. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity. World Journal of Gastroenterology 2015; 21(35): 10192-10199 doi: 10.3748/wjg.v21.i35.10192
|
| 46 |
Zhao-Chun Chi. Relationship between non-alcoholic fatty liver disease and cardiovascular disease. World Chinese Journal of Digestology 2020; 28(9) doi: 10.11569/wcjd.v28.i9.313
|
| 47 |
Shady Abohashem, Wesam Aldosoky, Taimur Abbasi, Tawseef Dar, Robert Rollings, Brian Tung, Basma Hammad, Fatima Saeed, Abdelrahman Ali, Richard A.P. Takx, Brian B. Ghoshhajra, Ahmed Tawakol, Michael T. Osborne. Hepatic steatosis associates with leukopoietic activity and atherosclerotic inflammation: mechanistic insights into cardiovascular risk. Metabolism 2026; 174 doi: 10.1016/j.metabol.2025.156427
|
| 48 |
Guy Bower, Thanos Athanasiou, Alberto M. Isla, Leanne Harling, Jia V. Li, Elaine Holmes, Evangelos Efthimiou, Ara Darzi, Hutan Ashrafian. Bariatric surgery and nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2015; 27(7) doi: 10.1097/MEG.0000000000000375
|
| 49 |
Theodoros Voulgaris, Vassilios A. Sevastianos. Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus. Hepatitis Research and Treatment 2016; 2016 doi: 10.1155/2016/7629318
|
| 50 |
Timothy E. Thayer, Christian L. Lino Cardenas, Trejeeve Martyn, Christopher J. Nicholson, Lisa Traeger, Florian Wunderer, Charles Slocum, Haakon Sigurslid, Hannah R. Shakartzi, Caitlin O’Rourke, Georgia Shelton, Mary D. Buswell, Hanna Barnes, Leif R. Neitzel, Clara D. Ledsky, Jason Pingcheng Li, Megan F. Burke, Eric Farber-Eger, Daniel S. Perrien, Ravindra Kumar, Kathleen E. Corey, Quinn S. Wells, Kenneth D. Bloch, Charles C. Hong, Donald B. Bloch, Rajeev Malhotra. The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66770-8
|
| 51 |
S. Taharboucht, R. Guermaz, M. Brouri, A. Chibane. Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population. JMV-Journal de Médecine Vasculaire 2021; 46(3) doi: 10.1016/j.jdmv.2021.03.008
|
| 52 |
Ko Maung, Sendhilnathan Ramalingam, Mohammad Chaudhry, Yi Ren, Sin-Ho Jung, Kristi Romero, Kelly Corbet, Nelson J. Chao, Taewoong Choi, Anna Mae Diehl, Louis Diehl, Cristina Gasparetto, Mitchell Horwitz, Gwynn Douglas Long, Richard D. Lopez, David A. Rizzieri, Stefanie Sarantopoulos, Keith M. Sullivan, Mustafa R. Bashir, Anthony D. Sung, Gianfranco D. Alpini. Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality. PLOS ONE 2020; 15(9) doi: 10.1371/journal.pone.0238824
|
| 53 |
Sara Heebøll, Jeyanthini Risikesan, Steffen Ringgaard, Indumathi Kumarathas, Thomas D. Sandahl, Henning Grønbæk, Esben Søndergaard, Søren Nielsen. Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD). Diabetes 2022; 71(11) doi: 10.2337/db22-0313
|
| 54 |
Xu Zhang, Maohua Wang, Daoming Bai, Rui Yang, Hanzhang Cao, Zhaojun Wang, Bing Guan, Chunping Yang. The Correlation Between the Prognostic Nutritional Index and Sudden Sensorineural Hearing Loss With Comorbid Nonalcoholic Fatty Liver Disease: A Prospective Study. Otology & Neurotology 2026; doi: 10.1097/MAO.0000000000004987
|
| 55 |
Jihyun Kim, Da Young Lee, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee, Susanne Kaser. Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation. PLOS ONE 2017; 12(7) doi: 10.1371/journal.pone.0180118
|
| 56 |
Yifei Lu, James R. Pike, Ron Hoogeveen, Keenan Walker, Laura Raffield, Elizabeth Selvin, Christy Avery, Stephanie Engel, Michelle M. Mielke, Tanya Garcia, Gerardo Heiss, Priya Palta. Nonalcoholic Fatty Liver Disease and Longitudinal Change in Imaging and Plasma Biomarkers of Alzheimer Disease and Vascular Pathology. Neurology 2024; 102(7) doi: 10.1212/WNL.0000000000209203
|
| 57 |
Shusei Yamamoto, Ikumi Sato, Natsuki Fukuhama, Natsumi Akiyama, Miku Sakai, Shota Kumazaki, Shang Ran, Satoshi Hirohata, Kazuya Kitamori, Yukio Yamori, Shogo Watanabe. Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in SHRSP5/Dmcr rat model. Experimental and Molecular Pathology 2020; 114 doi: 10.1016/j.yexmp.2020.104437
|
| 58 |
Zhihong Ma, Li Chu, Hongying Liu, Weijie Wang, Jieru Li, Wenzao Yao, Jianfeng Yi, Yue Gao. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats. Scientific Reports 2017; 7(1) doi: 10.1038/srep44819
|
| 59 |
Li-Zhen Wang, Wen-Qiang Li, Yao Li, Xiao-Yan Li, Shuai Ju. Assessing the impact of liver fat fraction on portal hemodynamics in nonalcoholic fatty liver disease using MRI proton density fat fraction and MRI 4D Flow. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1620649
|
| 60 |
Jie Han, Yong Wang, Zhongshang Yuan, Lu Liu, Meng Zhao, Qingbo Guan, Haiqing Zhang, Qiu Li, Jin Xu, Ling Gao, Jiajun Zhao, Xu Zhang. Nonalcoholic fatty liver disease represents a greater metabolic burden in patients with atherosclerosis. Medicine 2019; 98(11) doi: 10.1097/MD.0000000000014896
|
| 61 |
Maria Zachou, Pagona Flevari, Narjes Nasiri-Ansari, Constantinos Varytimiadis, Evangelos Kalaitzakis, Eva Kassi, Theodoros Androutsakos. The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review. European Journal of Clinical Pharmacology 2024; 80(1) doi: 10.1007/s00228-023-03586-1
|
| 62 |
Shogo Watanabe, Shota Kumazaki, Katsuhiro Kusunoki, Terumi Inoue, Yui Maeda, Shinichi Usui, Ryoko Shinohata, Takashi Ohtsuki, Satoshi Hirohata, Shozo Kusachi, Kazuya Kitamori, Mari Mori, Yukio Yamori, Hisao Oka. A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats. Journal of Atherosclerosis and Thrombosis 2018; 25(5) doi: 10.5551/jat.40956
|
| 63 |
Andrea Beyerle, Brandon Greene, Barbara Dietrich, Bronwyn A. Kingwell, Priya Panjwani, Samuel D. Wright, Eva Herzog. Co-administration of CSL112 (apolipoprotein A-I [human]) with atorvastatin and alirocumab is not associated with increased hepatotoxic or toxicokinetic effects in rats. Toxicology and Applied Pharmacology 2021; 422 doi: 10.1016/j.taap.2021.115557
|
| 64 |
Mayuko Ichimura, Akari Minami, Noriko Nakano, Yasuko Kitagishi, Toshiyuki Murai, Satoru Matsuda. Cigarette smoke may be an exacerbation factor in nonalcoholic fatty liver disease via modulation of the PI3K/AKT pathway. AIMS Molecular Science 2015; 2(4) doi: 10.3934/molsci.2015.4.427
|
| 65 |
Nevine I. Musa, Eslam Safwat, Sara M. Abdelhakam, Amir M. Farid, Waleed M. Hetta. Noninvasive tool for the diagnosis of NAFLD in association with atherosclerotic cardiovascular risk. Egyptian Liver Journal 2019; 9(1) doi: 10.1186/s43066-019-0002-y
|
| 66 |
YueRuiJing Liu, JinQi Wang, Rui Jin, ZongKai Xu, XiaoYu Zhao, YunFei Li, YanChen Zhao, ZhiYuan Wu, XiuHua Guo, LiXin Tao. Associations of Metabolic Dysfunction–Associated Fatty Liver Disease With Peripheral Artery Disease: Prospective Analysis in the UK Biobank and ARIC Study. Journal of the American Heart Association 2024; 13(22) doi: 10.1161/JAHA.124.035265
|
| 67 |
Youngjoon Kim, Yongin Cho, Yong‐ho Lee, Da Hea Seo, Seong Hee Ahn, Seongbin Hong, So Hun Kim. Association of lean metabolic dysfunction‐associated steatotic liver disease with carotid plaque progression in patients with type 2 diabetes mellitus. Journal of Diabetes Investigation 2025; 16(9) doi: 10.1111/jdi.70050
|
| 68 |
Stanley M.H. Chan, Stavros Selemidis, Steven Bozinovski, Ross Vlahos. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies. Pharmacology & Therapeutics 2019; 198 doi: 10.1016/j.pharmthera.2019.02.013
|
| 69 |
Rosanna Abbate, Nasser M. Al‐Daghri, Paolo Andreozzi, Niels Borregaard, Günay Can, Gianluca Caridi, Maren Carstensen‐Kirberg, Gabriele Cioni, Enrico Conte, Rosario Cuomo, Marie A. Denis, Gohar Fakhfouri, G. Fakhfouri, Renné Fiasse, Andreas Glenthøj, Georg Goliasch, Thomas Gremmel, Christian Herder, Maria Iemmolo, Zhi‐Cheng Jing, Robert Krause, Oreste Marrone, Bartosz Miazgowski, Tomasz Miazgowski, Lorenzo Minchiotti, Kazem Mousavizadeh, Gjin Ndrepepa, Alexander Niessner, Cristina Ogayar Luque, Altan Onat, Ioannis Papassotiriou, Martín Ruiz Ortiz, Shaun Sabico, C. Mary Schooling, Sophia D. Sakka, P. Sołtysiak, Frank L. J. Visseren, Jasmin Wagner, Xiao‐Jian Wang, Jan Westerink. Research update for articles published inEJCIin 2013. European Journal of Clinical Investigation 2015; 45(10) doi: 10.1111/eci.12512
|
| 70 |
Nathalie C. Leite, Cristiane A. Villela‐Nogueira, Marcel T. Ferreira, Claudia R. L. Cardoso, Gil F. Salles. Increasing aortic stiffness is predictive of advanced liver fibrosis in patients with type 2 diabetes: the Rio‐T2DM cohort study. Liver International 2016; 36(7) doi: 10.1111/liv.12994
|
| 71 |
Leonardo A. Sechi, Giorgio Soardo, Cristiana Catena. Nonalcoholic fatty liver and left ventricular remodelling: now the prospective evidence. Journal of Hypertension 2021; 39(5) doi: 10.1097/HJH.0000000000002750
|
| 72 |
Theodoros Androutsakos, Narjes Nasiri-Ansari, Athanasios-Dimitrios Bakasis, Ioannis Kyrou, Efstathios Efstathopoulos, Harpal S. Randeva, Eva Kassi. SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection. International Journal of Molecular Sciences 2022; 23(6) doi: 10.3390/ijms23063107
|
| 73 |
Amedeo Lonardo, Fabio Nascimbeni, Alessandro Mantovani, Giovanni Targher. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?. Journal of Hepatology 2018; 68(2) doi: 10.1016/j.jhep.2017.09.021
|
| 74 |
Giovanni Tarantino, Cristiana Porcu, Mario Arciello, Paola Andreozzi, Clara Balsano. Prediction of carotid intima–media thickness in obese patients with low prevalence of comorbidities by serum copper bioavailability. Journal of Gastroenterology and Hepatology 2018; 33(8) doi: 10.1111/jgh.14104
|
| 75 |
Kristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Charlotte Wilhelmina Wernberg, Lea Ladegaard Grønkjær, Peter Lykke Eriksen, Malene Flensborg Damholdt, Rajeshwar Prosad Mookerjee, Hendrik Vilstrup, Mette Munk Lauridsen, Karen Louise Thomsen. Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease—Current Knowledge, Mechanisms and Perspectives. Journal of Clinical Medicine 2021; 10(4) doi: 10.3390/jcm10040673
|
| 76 |
SOHEI IWANAGA, HIROO MATSUSE, RYUKI HASHIDA, MASAFUMI BEKKI, TAKUMI KAWAGUCHI, NAOTO SHIBA. The Effect of Walking Combined with Neuromuscular Electrical Stimulation on Liver Stiffness and Insulin Resistance in Patients with Non-alcoholic Fatty Liver Disease: An Exploratory Randomized Controlled Trial. The Kurume Medical Journal 2020; 67(4) doi: 10.2739/kurumemedj.MS674001
|
| 77 |
Nihat Aydın, Mustafa Capraz, Burcu Akman, Seyma Nur Altınok, Melek Tufek, Caner Kara. Does metabolic dysfunction-associated steatotic liver disease affect the ocular circulation?. Photodiagnosis and Photodynamic Therapy 2026; 57 doi: 10.1016/j.pdpdt.2026.105334
|
| 78 |
Shinsuke Nirengi, Mami Fujibayashi, Sachiko Furuno, Akihiko Uchibe, Yasuharu Kawase, Shin Sukino, Yaeko Kawaguchi, Satomi Minato, Kazuhiko Kotani, Naoki Sakane. Nonalcoholic Fatty Liver Disease in University Rugby Football Players. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00341
|
| 79 |
Maxine W. Stachel, Eugene C. DePasquale. Optimizing cardiac status in the preliver transplant candidate. Current Opinion in Organ Transplantation 2024; 29(1) doi: 10.1097/MOT.0000000000001119
|
| 80 |
Haiyan Zhang, Wen-Jun Shen, Yihang Li, Alex Bittner, Stefanie Bittner, Juveria Tabassum, Yuan F. Cortez, Fredric B. Kraemer, Salman Azhar. Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats. Nutrition & Metabolism 2016; 13(1) doi: 10.1186/s12986-016-0121-y
|
| 81 |
WEI CHEN, XIAOWEI WANG, LI HUANG, BO LIU. Hepcidin in non-alcoholic fatty liver disease regulated by the TLR4/NF-κB signaling pathway. Experimental and Therapeutic Medicine 2016; 11(1) doi: 10.3892/etm.2015.2873
|
| 82 |
Stefano Gitto, Ranka Vukotic, Giovanni Vitale, Martina Pirillo, Erica Villa, Pietro Andreone. Non-alcoholic steatohepatitis and liver transplantation. Digestive and Liver Disease 2016; 48(6) doi: 10.1016/j.dld.2016.02.014
|
| 83 |
Peiyan Du, Jianxiang Jiang, Yurong Liu, Haihong Lv. Correlation between vascular endothelial function and bone mineral density in type 2 diabetes mellitus patients with MAFLD. Acta Cardiologica 2025; 80(1) doi: 10.1080/00015385.2024.2436813
|
| 84 |
Karn Wijarnpreecha, Charat Thongprayoon, Boonphiphop Boonpheng, Panadeekarn Panjawatanan, Konika Sharma, Patompong Ungprasert, Surakit Pungpapong, Wisit Cheungpasitporn. Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2018; 30(9) doi: 10.1097/MEG.0000000000001169
|
| 85 |
Lei Liu, Changfa Wang, Shuwen Deng, Ting Yuan, Xiaoling Zhu, Yuling Deng, Yuexiang Qin, Yaqin Wang, Pingting Yang. Transition patterns of metabolic dysfunction-associated fatty liver disease status in relation to arterial stiffness progression: a health check-up cohort study. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-35733-0
|
| 86 |
Kun Tang, Fei Wang, Yi Zeng, XueMeng Chen, XiaoLe Xu. Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient mice. European Journal of Pharmacology 2018; 830 doi: 10.1016/j.ejphar.2018.04.026
|
| 87 |
Justin A Steggerda, Krishnaraj Mahendraraj, Tsuyoshi Todo, Mazen Noureddin. Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge. World Journal of Gastroenterology 2020; 26(28): 4018-4035 doi: 10.3748/wjg.v26.i28.4018
|
| 88 |
Konstantinos Kargiotis, Vasilios G Athyros, Olga Giouleme, Niki Katsiki, Evangelia Katsiki, Panagiotis Anagnostis, Chrysoula Boutari, Michael Doumas, Asterios Karagiannis, Dimitri P Mikhailidis. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome. World Journal of Gastroenterology 2015; 21(25): 7860-7868 doi: 10.3748/wjg.v21.i25.7860
|
| 89 |
Jella-Andrea Abraham, Olga Golubnitschaja. Time for Paradigm Change in Management of Hepatocellular Carcinoma: Is a Personalized Approach on the Horizon?. Personalized Medicine 2016; 13(5) doi: 10.2217/pme-2016-0013
|
| 90 |
Masato Yoneda, Takuma Yamamoto, Yasushi Honda, Kento Imajo, Yuji Ogawa, Takaomi Kessoku, Takashi Kobayashi, Asako Nogami, Takuma Higurashi, Shingo Kato, Kunihiro Hosono, Satoru Saito, Atsushi Nakajima. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan. Journal of Gastroenterology 2021; 56(11) doi: 10.1007/s00535-021-01828-6
|
| 91 |
Gjin Ndrepepa, Roisin Colleran, Adnan Kastrati. Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease. Clinica Chimica Acta 2018; 476 doi: 10.1016/j.cca.2017.11.026
|
| 92 |
Hande Erman, Banu Boyuk, Seyma Arslan, Seydahmet Akin, Özcan Keskin. Noninvasive Liver Fibrosis Indices as Indicators of Microvascular and Macrovascular Complications in Type 2 Diabetes. Metabolic Syndrome and Related Disorders 2024; 22(8) doi: 10.1089/met.2024.0022
|
| 93 |
Vasilios G Athyros, Konstantinos Tziomalos, Niki Katsiki, Michael Doumas, Asterios Karagiannis, Dimitri P Mikhailidis. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. World Journal of Gastroenterology 2015; 21(22): 6820-6834 doi: 10.3748/wjg.v21.i22.6820
|
| 94 |
Giovanni Tarantino, Susan Costantini, Vincenzo Citro, Paolo Conforti, Francesca Capone, Angela Sorice, Domenico Capone. Interferon-alpha 2 but not Interferon-gamma serum levels are associated with intramuscular fat in obese patients with nonalcoholic fatty liver disease. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-018-1754-6
|
| 95 |
Mirah Khalid Alshehhi, Asiya Nazir. Microbiome Therapeutics. 2023; doi: 10.1016/B978-0-323-99336-4.00010-0
|
| 96 |
Doaa El Amrousy, Esam Elgendy, Mohiee El-Deen Awad, Osama El Razaky. Three-dimensional speckle tracking echocardiography for early detection of left ventricular dysfunction in children with non-alcoholic fatty liver diseases. Cardiology in the Young 2021; 31(4) doi: 10.1017/S104795112000445X
|
| 97 |
Young Dae Kim, Dongbeom Song, Ji Hoe Heo, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang Joon Kim, Kwang-Hyub Han, Friedemann Paul. Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography. PLOS ONE 2015; 10(9) doi: 10.1371/journal.pone.0139227
|
| 98 |
Martyna Wojtala, Luciano Pirola, Aneta Balcerczyk. Modulation of the vascular endothelium functioning by dietary components, the role of epigenetics. BioFactors 2017; 43(1) doi: 10.1002/biof.1306
|
| 99 |
Yu Dong, Guangsen Li. Cardiac abnormalities in patients with nonalcoholic fatty liver disease. Herz 2021; 46(2) doi: 10.1007/s00059-019-04855-5
|
| 100 |
R. Sivaraj, S. Jaikumar, S. Sengottuvelu. Zingiberene attenuates high fat diet–induced non-alcoholic fatty liver disease through suppression of lipogenesis and oxidative stress in rats. Comparative Clinical Pathology 2022; 31(2) doi: 10.1007/s00580-022-03321-9
|
| 101 |
Qing Lv, Qianqian Han, Ziyun Wen, Yunyun Pan, Jisheng Chen. The association between atherosclerosis and nonalcoholic fatty liver disease. Medicine 2024; 103(1) doi: 10.1097/MD.0000000000036815
|
| 102 |
Adriene A. Paiva, Helena F. Raposo, Amarylis C. B. A. Wanschel, Tarlliza R. Nardelli, Helena C. F. Oliveira, Ruchi Shah. Apolipoprotein CIII Overexpression‐Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death. Oxidative Medicine and Cellular Longevity 2017; 2017(1) doi: 10.1155/2017/1838679
|
| 103 |
John N. Stabley, Dwight A. Towler. Arterial Calcification in Diabetes Mellitus. Arteriosclerosis, Thrombosis, and Vascular Biology 2017; 37(2) doi: 10.1161/ATVBAHA.116.306258
|
| 104 |
Ivica Grgurevic, Kristian Podrug, Ivana Mikolasevic, Michal Kukla, Anita Madir, Emmanuel A. Tsochatzis. Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach. Canadian Journal of Gastroenterology and Hepatology 2020; 2020 doi: 10.1155/2020/9181368
|
| 105 |
So Yeong Cheon, Juhyun Song. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation. Cell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00836-0
|
| 106 |
Roxana Gutiérrez-Vidal, Blanca Delgado-Coello, Kevin Manuel Méndez-Acevedo, Sandra Calixto-Tlacomulco, Salvador Damián-Zamacona, Jaime Mas-Oliva. Therapeutic Intranasal Vaccine HB-ATV-8 Prevents Atherogenesis and Non-alcoholic Fatty Liver Disease in a Pig Model of Atherosclerosis. Archives of Medical Research 2018; 49(7) doi: 10.1016/j.arcmed.2019.01.007
|
| 107 |
Ping Lin, Kai-Wen Kan, Jia-Haur Chen, Yung-Kai Lin, Yung-Hao Lin, Yung-Hsiang Lin, Wei-Chun Hu, Chi-Fu Chiang, Chen-Meng Kuan, Antonella Fioravanti. Investigation of the Synergistic Effect of Brown Sugar, Longan, Ginger, and Jujube (Brown Sugar Longan Ginger Tea) on Antioxidation and Anti‐Inflammation in In Vitro Models. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/3596085
|
| 108 |
Muammer Kara, Teoman Dogru, Halil Genc, Erdim Sertoglu, Gurkan Celebi, Hasan Gurel, Hüseyin Kayadibi, Ali F. Cicek, Cemal N. Ercin, Alper Sonmez. Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2015; 27(10) doi: 10.1097/MEG.0000000000000405
|
| 109 |
Antonino Tuttolomondo, Salvatore Petta, Alessandra Casuccio, Carlo Maida, Vittoriano Della Corte, Mario Daidone, Domenico Di Raimondo, Rosaria Pecoraro, Roberto Fonte, Anna Cirrincione, Rita Zafonte, Daniela Cabibi, Calogero Cammà, Vito Di Marco, Anna Licata, Franco Magliozzo, Giulio Marchesini, Giovanni Merlino, Antonio Craxì, Antonio Pinto. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. Cardiovascular Diabetology 2018; 17(1) doi: 10.1186/s12933-018-0670-7
|
| 110 |
Ziheng Wei, Yurun Xue, Yucong Xue, Jie Cheng, Guoping Lv, Li Chu, Zhihong Ma, Shengjiang Guan. Ferulic acid attenuates non-alcoholic steatohepatitis by reducing oxidative stress and inflammation through inhibition of the ROCK/NF-κB signaling pathways. Journal of Pharmacological Sciences 2021; 147(1) doi: 10.1016/j.jphs.2021.05.006
|
| 111 |
Marta Freitas, Vítor Macedo Silva, Sofia Xavier, Joana Magalhães, Carla Marinho, José Cotter. Early Kidney Dysfunction in Metabolic-Associated Fatty Liver Disease: Is Transient Elastography Useful as a Screening Method?. Digestive Diseases 2021; 39(6) doi: 10.1159/000514811
|
| 112 |
Gordana Kenđel Jovanović, Ines Mrakovcic-Sutic, Sandra Pavičić Žeželj, Indira Benjak Horvat, Lucia Šuša, Dario Rahelić, Sanja Klobučar Majanović, Branka Filipović. Metabolic and Hepatic Effects of Energy‐Reduced Anti‐Inflammatory Diet in Younger Adults with Obesity. Canadian Journal of Gastroenterology and Hepatology 2021; 2021(1) doi: 10.1155/2021/6649142
|
| 113 |
Antonella Amato, Gaetano-Felice Caldara, Domenico Nuzzo, Sara Baldassano, Pasquale Picone, Manfredi Rizzo, Flavia Mulè, Marta Di Carlo. NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet. Nutrients 2017; 9(5) doi: 10.3390/nu9050492
|
| 114 |
Stefano Gitto, Nicola de Maria, Fabrizio di Benedetto, Giuseppe Tarantino, Valentina Serra, Lorenzo Maroni, Matteo Cescon, Antonio D. Pinna, Filippo Schepis, Pietro Andreone, Erica Villa. De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients. European Journal of Gastroenterology & Hepatology 2018; 30(7) doi: 10.1097/MEG.0000000000001105
|
| 115 |
S.M. Clifford, D.J. Murphy. Non-alcoholic fatty liver disease and coronary atherosclerosis-does myocardial glucose metabolism provide the missing link?. Journal of Nuclear Cardiology 2021; 28(2) doi: 10.1007/s12350-019-01783-z
|
| 116 |
Yao-Shuang Li, Yu-Ge Xia, Yan-Lan Liu, Wei-Ran Jiang, Hui-Na Qiu, Fan Wu, Jing-Bo Li, Jing-Na Lin, Ming-Lung Yu. Metabolic-dysfunction associated steatotic liver disease-related diseases, cognition and dementia: A two-sample mendelian randomization study. PLOS ONE 2024; 19(2) doi: 10.1371/journal.pone.0297883
|
| 117 |
Ziyi Yang, Jia Li, Jie Zhang, Chao Sun. Magnesium Deficiency: The Insidious Executor of the Liver Disease. Journal of the American Nutrition Association 2025; 44(5) doi: 10.1080/27697061.2024.2443063
|
| 118 |
Rong-Rong Zhu, Xu-Ping Gao, Min-Qi Liao, Yun-Feng Cui, Si-Xian Tan, Fang-Fang Zeng, Yan-Mei Lou, Chang-Yi Wang, Shan Xu, Xiao-Lin Peng, Shu-Hong Dai, Dan Zhao, Li Wang, Zhao Ping, Xiao-Yu Dai, Pin-Ning Feng, Li-Yuan Han. Non-alcoholic Fatty Liver Disease Is Associated With Aortic Calcification: A Cohort Study With Propensity Score Matching. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.880683
|
| 119 |
John Guirguis, Jagpreet Chhatwal, Jaividhya Dasarathy, John Rivas, David McMichael, Laura E. Nagy, Arthur J. McCullough, Srinivasan Dasarathy. Clinical Impact of Alcohol‐Related Cirrhosis in the Next Decade: Estimates Based on Current Epidemiological Trends in the United States. Alcoholism: Clinical and Experimental Research 2015; 39(11) doi: 10.1111/acer.12887
|
| 120 |
Pegah Golabi, Natsu Fukui, James Paik, Mehmet Sayiner, Alita Mishra, Zobair M. Younossi. Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease. Hepatology Communications 2019; 3(8) doi: 10.1002/hep4.1387
|
| 121 |
Doris Ogresta, Anna Mrzljak, Maja Cigrovski Berkovic, Ines Bilic-Curcic, Sanja Stojsavljevic-Shapeski, Lucija Virovic-Jukic. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. Journal of Clinical and Translational Hepatology 2022; 10(2) doi: 10.14218/JCTH.2021.00268
|
| 122 |
A. Yu. Timakova, Yu. P. Skirdenko, M. A. Livzan, T. S. Krolevets, N. A. Nikolaev, A. V. Nelidova. Cardiovascular comorbidity in non-alcoholic fatty liver disease. Experimental and Clinical Gastroenterology 2020; (10) doi: 10.31146/1682-8658-ecg-182-10-88-95
|
| 123 |
Lauren K. Truby, Robert J. Mentz, Richa Agarwal. Cardiovascular risk stratification in the noncardiac solid organ transplant candidate. Current Opinion in Organ Transplantation 2022; 27(1) doi: 10.1097/MOT.0000000000000942
|
| 124 |
Hye Young Kim, Young Hyun Yoo. The Role of STAMP2 in Pathogenesis of Chronic Diseases Focusing on Nonalcoholic Fatty Liver Disease: A Review. Biomedicines 2022; 10(9) doi: 10.3390/biomedicines10092082
|
| 125 |
Yuna Kim, Eugene Han, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Mi Kyung Kim, Hye Soon Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Yong-ho Lee, Seung Up Kim. Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease. Gut and Liver 2022; 16(2) doi: 10.5009/gnl210084
|
| 126 |
Anders Gummesson, Ulf Strömberg, Caroline Schmidt, Joel Kullberg, Oskar Angerås, Stefan Lindgren, Ola Hjelmgren, Kjell Torén, Annika Rosengren, Björn Fagerberg, John Brandberg, Göran Bergström, Pavel Strnad. Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects. PLOS ONE 2018; 13(8) doi: 10.1371/journal.pone.0202666
|
| 127 |
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016; 65(8) doi: 10.1016/j.metabol.2016.05.003
|
| 128 |
Lo-Yip Yu, Kuang-Chun Hu, Chun-Jen Liu, Chung-Lieh Hung, Ming-Jong Bair, Ming-Jen Chen, Horng-Yuan Wang, Ming-Shiang Wu, Shou-Chuan Shih, Chuan-Chuan Liu. Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis. Medicine 2019; 98(9) doi: 10.1097/MD.0000000000014672
|
| 129 |
Cinthia Choque Vargas, Francisco Cáceres, Graciela Landeira, Soledad Perez, Laura Marchi, Gabriela Ruffillo, Silvina Tevez, Miguel Puga-Tejada, Eduardo Fassio. Cardiovascular events and incident diabetes in 220 patients with MASLD according to basal liver fibrosis: a 10-year follow-up historic cohort. European Journal of Gastroenterology & Hepatology 2025; 37(5) doi: 10.1097/MEG.0000000000002943
|
| 130 |
Seung Up Kim, Dongbeom Song, Ji Hoe Heo, Joonsang Yoo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang Joon Kim, Kwang-Hyub Han, Young Dae Kim. Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke. Atherosclerosis 2017; 260 doi: 10.1016/j.atherosclerosis.2017.02.005
|
| 131 |
Louis Papageorgiou, Eleni Papakonstantinou, Io Diakou, Katerina Pierouli, Konstantina Dragoumani, Flora Bacopoulou, George P. Chrousos, Elias Eliopoulos, Dimitrios Vlachakis. GeNeDis 2022. Advances in Experimental Medicine and Biology 2023; 1423 doi: 10.1007/978-3-031-31978-5_6
|
| 132 |
A. Baragetti, G. Pisano, C. Bertelli, K. Garlaschelli, L. Grigore, A.L. Fracanzani, S. Fargion, G.D. Norata, A.L. Catapano. Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population. Nutrition, Metabolism and Cardiovascular Diseases 2016; 26(2) doi: 10.1016/j.numecd.2015.10.013
|
| 133 |
Sampada, Mohammad Naseem, Mehul Solanki, Ragini Sharma, Carol Singh, Aalam Sohal. Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease. World Journal of Gastrointestinal Pathophysiology 2025; 16(4): 111029 doi: 10.4291/wjgp.v16.i4.111029
|
| 134 |
Gholamreza Bazmandegan, Mitra Abbasifard, Ali Esmaeili Nadimi, Hasan Alinejad, Zahra Kamiab. Cardiovascular risk factors in diabetic patients with and without metabolic syndrome: a study based on the Rafsanjan cohort study. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-022-27208-5
|
| 135 |
Ran Jin, Ngoc-Anh Le, Rebecca Cleeton, Xiaoyan Sun, Jessica Cruz Muños, James Otvos, Miriam B Vos. Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents. Lipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0038-x
|
| 136 |
Jong Wook Choi, Il Hwan Oh, Chang Hwa Lee, Joon-Sung Park. Is there a J-shaped relationship between the fatty liver index and risk of microalbuminuria in the general population?. Clinica Chimica Acta 2018; 481 doi: 10.1016/j.cca.2017.08.015
|
| 137 |
Rosa Lombardi, Lorena Airaghi, Giovanni Targher, Gaetano Serviddio, Gabriele Maffi, Alessandro Mantovani, Claudio Maffeis, Antonio Colecchia, Rosanna Villani, Luca Rinaldi, Emanuela Orsi, Giuseppina Pisano, Luigi E. Adinolfi, Silvia Fargion, Anna L. Fracanzani. Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes. Liver International 2020; 40(2) doi: 10.1111/liv.14274
|
| 138 |
Shanshan Liu, Jialu Wang, Shujing Wu, Jingya Niu, Ruizhi Zheng, Lizhan Bie, Zhuojun Xin, Shuangyuan Wang, Hong Lin, Zhiyun Zhao, Tiange Wang, Min Xu, Jieli Lu, Yuhong Chen, Yiping Xu, Weiqing Wang, Guang Ning, Yufang Bi, Mian Li, Yu Xu. The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis. Metabolism 2021; 120 doi: 10.1016/j.metabol.2021.154779
|
| 139 |
Nicholas W.S. Chew, Mark D. Muthiah, Arun J. Sanyal. Cardiovascular Endocrinology and Metabolism. 2023; doi: 10.1016/B978-0-323-99991-5.00003-6
|
| 140 |
Ho Cheol Hong, Soon Young Hwang, Ja Young Ryu, Hye Jin Yoo, Ji‐A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Dong Seop Choi, Kyung Mook Choi. The synergistic impact of nonalcoholic fatty liver disease and metabolic syndrome on subclinical atherosclerosis. Clinical Endocrinology 2016; 84(2) doi: 10.1111/cen.12940
|
| 141 |
Zhuojun Xin, Yuanyue Zhu, Shuangyuan Wang, Shanshan Liu, Min Xu, Tiange Wang, Jieli Lu, Yuhong Chen, Zhiyun Zhao, Weiqing Wang, Guang Ning, Yufang Bi, Yu Xu, Mian Li. Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non‐invasive score. Liver International 2020; 40(4) doi: 10.1111/liv.14322
|
| 142 |
Francesco De Chiara, Ainhoa Ferret-Miñana, Javier Ramón-Azcón. The Synergy between Organ-on-a-Chip and Artificial Intelligence for the Study of NAFLD: From Basic Science to Clinical Research. Biomedicines 2021; 9(3) doi: 10.3390/biomedicines9030248
|
| 143 |
Andriana C. Kaliora, Aristea Gioxari, Ioanna Panagiota Kalafati, Anastasia Diolintzi, Alexandros Kokkinos, George V. Dedoussis. The Effectiveness of Mediterranean Diet in Nonalcoholic Fatty Liver Disease Clinical Course: An Intervention Study. Journal of Medicinal Food 2019; 22(7) doi: 10.1089/jmf.2018.0020
|
| 144 |
Theodor Baars, Robert K. Gieseler, Polykarpos C. Patsalis, Ali Canbay. Towards harnessing the value of organokine crosstalk to predict the risk for cardiovascular disease in non-alcoholic fatty liver disease. Metabolism 2022; 130 doi: 10.1016/j.metabol.2022.155179
|
| 145 |
Sacha El Khoury, Sami N. Al Harake, Tya Youssef, Carl E. Risk, Naim G. Helou, Natalie M. Doumet, Karl Aramouni, Sami Azar, Sonia M. Najjar, Hilda E. Ghadieh. Low Hepatic CEACAM1 Tethers Metabolic Dysfunction Steatohepatitis to Atherosclerosis. Livers 2025; 5(3) doi: 10.3390/livers5030034
|
| 146 |
Xiao-Hui Song, Bo Liu, Fang Lei, Ye-Mao Liu, Xingyuan Zhang, Ze Chen, Peng Zhang, Xiao-Jing Zhang, Zhi-Gang She, Jingjing Cai, Jin-Hua Wang, Hongliang Li. The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese Population. Diabetes, Metabolic Syndrome and Obesity 2023; doi: 10.2147/DMSO.S394414
|
| 147 |
Taeang Arai, Masanori Atsukawa, Akihito Tsubota, Tadamichi Kawano, Mai Koeda, Yuji Yoshida, Tomohide Tanabe, Tomomi Okubo, Korenobu Hayama, Ai Iwashita, Norio Itokawa, Chisa Kondo, Keiko Kaneko, Chiaki Kawamoto, Tsutomu Hatori, Naoya Emoto, Etsuko Iio, Yasuhito Tanaka, Katsuhiko Iwakiri, Jee-Fu Huang. Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease. PLOS ONE 2019; 14(11) doi: 10.1371/journal.pone.0224184
|
| 148 |
Giovanni Targher, Stefano Zona, Dante Romagnoli, Fabio Nascimbeni, Giovanni Guaraldi, Stefano Ballestri, Amedeo Lonardo. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World Journal of Gastroenterology 2016; 22(44): 9674-9693 doi: 10.3748/wjg.v22.i44.9674
|
| 149 |
Amreen Dinani, Arun Sanyal. Nonalcoholic fatty liver disease: implications for cardiovascular risk. Cardiovascular Endocrinology 2017; 6(2) doi: 10.1097/XCE.0000000000000126
|
| 150 |
Sanda Mustapic, Sead Ziga, Vladimir Matic, Tomislav Bokun, Bozo Radic, Marko Lucijanic, Srecko Marusic, Zarko Babic, Ivica Grgurevic. Ultrasound Grade of Liver Steatosis Is Independently Associated with the Risk of Metabolic Syndrome. Canadian Journal of Gastroenterology and Hepatology 2018; 2018 doi: 10.1155/2018/8490242
|
| 151 |
Meng-Ting Tsou, Jau-Yuan Chen. Gender-Based Association of Coronary Artery Calcification and Framingham Risk Score With Non-alcoholic Fatty Liver Disease and Abdominal Obesity in Taiwanese Adults, a Cross-Sectional Study. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.803967
|
| 152 |
Noa Zolberg Relevy, Dror Harats, Ayelet Harari, Ami Ben-Amotz, Rafael Bitzur, Ralph Rühl, Aviv Shaish. Vitamin A-Deficient Diet Accelerated Atherogenesis in Apolipoprotein E−/−Mice and Dietaryβ-Carotene Prevents This Consequence. BioMed Research International 2015; 2015 doi: 10.1155/2015/758723
|
| 153 |
Cristiane Villela-Nogueira, Nathalie Leite, Claudia Cardoso, Gil Salles. NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?. International Journal of Molecular Sciences 2016; 17(4) doi: 10.3390/ijms17040460
|
| 154 |
Hyeok-Hee Lee, Yongin Cho, Young Ju Choi, Byung Wook Huh, Byung-Wan Lee, Eun Seok Kang, Seok Won Park, Bong-Soo Cha, Eun Jig Lee, Yong-ho Lee, Kap Bum Huh. Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study. Cardiovascular Diabetology 2020; 19(1) doi: 10.1186/s12933-020-01064-x
|
| 155 |
Yogesh Kumar Gupta, Sahil Nohria, Varun Mehta, Bishav Mohan. To Determine the Prevalence and Correlation of Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease. Indian Journal of Public Health 2026; doi: 10.4103/ijph.ijph_824_25
|
| 156 |
Muhammad Sharjeel Abbas, Mrunalini Dandamudi, Tooba Rehman, Muhammad Aqib Faizan, Izza Zahra, John Cedric Mojica, Musab Riyan Ahmed, Karishma Bai, Izza Shakeel, Zunaira Shahzad, Juliana Giorgi. “Efficacy of SGLT2 inhibitors in non-diabetic non-alcoholic fatty liver disease: a systematic review and meta-analysis”. Journal of Diabetes & Metabolic Disorders 2025; 24(2) doi: 10.1007/s40200-025-01797-0
|
| 157 |
Shogo Watanabe, Shota Kumazaki, Shusei Yamamoto, Ikumi Sato, Kazuya Kitamori, Mari Mori, Yukio Yamori, Satoshi Hirohata. Non‐alcoholic steatohepatitis aggravates nitric oxide synthase inhibition‐induced arteriosclerosis in SHRSP5/Dmcr rat model. International Journal of Experimental Pathology 2018; 99(6) doi: 10.1111/iep.12301
|
| 158 |
Narendra S. Choudhary, Ajay Duseja. Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?. Journal of Clinical and Experimental Hepatology 2019; 9(4) doi: 10.1016/j.jceh.2019.02.005
|
| 159 |
Sunmin Park, Ting Zhang, Jing Yi Qiu, Xuangao Wu. The Combination of Mulberry Extracts and Silk Amino Acids Alleviated High Fat Diet-Induced Nonalcoholic Hepatic Steatosis by Improving Hepatic Insulin Signaling and Normalizing Gut Microbiome Dysbiosis in Rats. Evidence-Based Complementary and Alternative Medicine 2019; 2019 doi: 10.1155/2019/8063121
|
| 160 |
Rehab F. Abdel-Rahman. Non-alcoholic fatty liver disease. Asian Pacific Journal of Tropical Biomedicine 2022; 12(3) doi: 10.4103/2221-1691.338919
|
| 161 |
Kui Cui, Yunzhou Dong, Beibei Wang, Douglas B. Cowan, Siu-Lung Chan, John Shyy, Hong Chen. Endocytic Adaptors in Cardiovascular Disease. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.624159
|
| 162 |
Shimaa A. Sadek, Asmaa E. Farouk, Sohair R. Fahmy, Amel M. Soliman. Holothuria arenicola Extract Attenuated Hepatic Steatosis in Splenectomized
Rat Fed High Fat Diet. The Natural Products Journal 2022; 12(3) doi: 10.2174/2210315511666210927122059
|
| 163 |
Dongdong Fu, Shuai Wu, Xiangfu Jiang, Tingyu You, Yu Li, Jiao Xin, Xiaowen Feng, Jiagen Wen, Yan Huang, Chengmu Hu. Caveolin-1 alleviates acetaminophen-induced vascular oxidative stress and inflammation in non-alcoholic fatty liver disease. Free Radical Biology and Medicine 2023; 195 doi: 10.1016/j.freeradbiomed.2022.12.095
|
| 164 |
Masayoshi Takeuchi, Jun-ichi Takino, Akiko Sakasai-Sakai, Takanobu Takata, Mikihiro Tsutsumi. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD. Nutrients 2017; 9(6) doi: 10.3390/nu9060634
|
| 165 |
Nathan C. Winn, Ying Liu, R. Scott Rector, Elizabeth J. Parks, Jamal A. Ibdah, Jill A. Kanaley. Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity — A randomized trial. Metabolism 2018; 78 doi: 10.1016/j.metabol.2017.08.012
|
| 166 |
Mirella Pastore, Stefania Grimaudo, Rosaria Maria Pipitone, Giulia Lori, Chiara Raggi, Salvatore Petta, Fabio Marra. Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00604
|
| 167 |
Eleonora Scorletti, Christopher D. Byrne. Non-Alcoholic Fatty Liver Disease. 2020; doi: 10.1007/978-3-319-95828-6_9
|
| 168 |
Giovanni Tarantino, Luigi Barrea, Domenico Capone, Vincenzo Citro, Teresa Mosca, Silvia Savastano. Hematocrit Values Predict Carotid Intimal-Media Thickness in Obese Patients With Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00203
|
| 169 |
A Lum Han. Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease. Diabetology & Metabolic Syndrome 2022; 14(1) doi: 10.1186/s13098-022-00811-2
|